Skip to main content
UniHealth

Doctor search

Lauren Elaine Eggert, MD

Critical Care (Intensivists) · Burlingame

NPI 1366784274

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
4
2 carriers
Offices
4

Offices

4 locations · UCSF Medical Group Business Services · Regents of the University of California

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley · UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

4 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Eggert’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

4 of 4 plans

Plans whose provider directory lists this clinician
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A148609 · Current

Licensed to practise in California · since 2017 · expires 2026-12-31 · Albert Einstein College of Medicine of Yeshiva University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$67,132

Medicare paid this office $67,132 for 417 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Critical care, first 30-74 minutes96$34,139$181
Short return visit (20+ min)58$6,011$75
Return visit (30+ min)32$5,022$117
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$4,238$106
Return visit (30+ min)29$2,898$83
See all 13 services
Every Original Medicare service billed
Critical care, first 30-74 minutes96$34,139$181
Short return visit (20+ min)58$6,011$75
Return visit (30+ min)32$5,022$117
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$4,238$106
Return visit (30+ min)29$2,898$83
New patient visit (60+ min)15$1,956$130
Initial hospital care with moderate level of medical decision making at least 75 minutes11$1,706$155
Critical care, each additional 30 minutes11$1,570$92
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes13$911$70
Test to examine how well the lungs exchange gases93$696$7
Test to measure expiratory airflow and volume82$592$7
Test to measure expiratory airflow and volume changes before and after medication administration61$508$8
Test to determine lung volumes using sensors35$348$10

Who their Medicare patients are

417 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 13% · Women 56% · Also on Medicaid 29% · Health risk score 2.21. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.

Conditions among them: High blood pressure 75% · COPD 40% · Coronary heart disease 36% · Diabetes 35% · Chronic kidney disease 32% · Heart failure 31% · Atrial fibrillation 29% · Depression 25% · Cancer 19% · Dementia 14% · Stroke 12%.

The office billed $521,950, Medicare allowed $87,328 and paid $67,132; for 823 services of 27 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024417823742.21$521,950$67,132
2023392854742.27$450,995$58,678
2022384774742.29$604,426$78,594
2021320736722.00$365,936$53,370
202099192722.02$154,094$19,868
20177493802.85$63,167$12,379
2016148201802.21$135,515$28,041

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 14 services

Original Medicare services billed in 2023
Critical care, first 30-74 minutes71$25,200$189
Short return visit (20+ min)40$4,502$74
Return visit (30+ min)21$3,335$111
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes23$3,291$110
Return visit (30+ min)32$3,071$83
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$2,772$73
Initial hospital care with moderate level of medical decision making at least 75 minutes16$2,411$151
Telehealth originating site facility fee51$1,958$21
Long return visit (40+ min)15$1,824$122
Critical care, each additional 30 minutes11$1,426$95
Test to examine how well the lungs exchange gases108$805$7
Test to measure expiratory airflow and volume89$611$7
Test to measure expiratory airflow and volume changes before and after medication administration70$572$8
Test to determine lung volumes using sensors45$449$10

2022: 15 services

Original Medicare services billed in 2022
Critical care, first 30-74 minutes94$39,055$191
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes51$6,577$94
Initial hospital care with moderate level of medical decision making at least 75 minutes28$5,284$182
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes46$3,978$65
Short return visit (20+ min)28$3,818$78
Return visit (30+ min)29$2,797$85
Return visit (30+ min)15$2,379$113
New patient visit (60+ min)14$2,364$169
Telehealth originating site facility fee43$1,418$20
Hospital discharge day management, more than 30 minutes13$1,260$97
Short return visit (20+ min)19$1,025$49
Test to examine how well the lungs exchange gases38$318$8
Test to measure expiratory airflow and volume36$279$8
Test to measure expiratory airflow and volume changes before and after medication administration24$226$9
Test to determine lung volumes using sensors13$143$11

2021: 13 services

Original Medicare services billed in 2021
Critical care, first 30-74 minutes56$22,815$193
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$3,184$88
New patient visit (60+ min)15$2,874$192
Short return visit (20+ min)25$2,751$86
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes19$2,232$66
New patient visit (60+ min)11$1,999$182
Short return visit (20+ min)17$1,454$61
Return visit (30+ min)14$1,343$90
Telehealth originating site facility fee38$1,286$21
Test to examine how well the lungs exchange gases98$809$8
Test to measure expiratory airflow and volume changes before and after medication administration66$640$10
Test to determine lung volumes using sensors49$547$11
Test to measure expiratory airflow and volume65$496$8

2020: 3 services

Original Medicare services billed in 2020
Critical care, first 30-74 minutes30$11,230$201
Telehealth originating site facility fee12$288$22
Test to examine how well the lungs exchange gases14$120$9

2017: 2 services

Original Medicare services billed in 2017
Initial hospital care with moderate level of medical decision making at least 75 minutes48$8,435$172
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$1,992$95

2016: 3 services

Original Medicare services billed in 2016
Initial hospital care with moderate level of medical decision making at least 75 minutes107$19,905$184
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes35$4,429$94
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$2,082$65

Medicaid work

$5,871 in 2024

Medicaid paid $5,871 for 117 billed services this clinician did in 2024, up to 22 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes27$5,278
Diffusing capacity53$290
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation22$167
EVALUATION OF WHEEZING15$136
Medicaid work by year
2024117422$5,871
202396420$13,306
202227215$131
202125213$365
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes43$12,792
Telehealth originating site facility fee12$306
Diffusing capacity28$131
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation13$77

2022

Largest Medicaid services in 2022
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation15$68
Diffusing capacity12$64

2021

Largest Medicaid services in 2021
Telehealth originating site facility fee12$277
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation13$88

Drugs they prescribed that Part D paid

$483,408

Pharmacies billed $483,408 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 542) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.

192 generic and 350 brand-name prescriptions · $483,408 in drug cost · 14 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Xolair28$100,457$3,588
Trelegy Ellipta112$85,986$768
Fasenra14$73,476$5,248
Dupixent17$69,859$4,109
Nucala14$51,000$3,643
See all 16 drugs
Every Part D drug this clinician prescribed
Xolair28$100,457$3,588
Trelegy Ellipta112$85,986$768
Fasenra14$73,476$5,248
Dupixent17$69,859$4,109
Nucala14$51,000$3,643
Breztri Aerosphere28$18,191$650
Breo Ellipta18$11,224$624
Breyna20$6,250$313
Symbicort18$5,927$329
Advair Hfa18$5,773$321
Wixela Inhub16$889$56
Albuterol Sulfate Hfa25$670$27
Montelukast31$306$10
Fluticasone Propionate15$243$16
Prednisone32$170$5
Levocetirizine Dihydrochloride15$101$7

Year by year

Part D prescribing by year
2024542890% (0)65%$483,408
2023509830% (0)71%$435,946
202255099None65%$316,969
2021321630% (0)62%$158,220
202096230% (0)46%$27,696
201734130% (0)None$3,593
201660062NoneNone$29,506
201572170% (0)17%$3,912
20143817NoneNone$1,429
201322NoneNoneNone$1,779

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 13 drugs

Part D drugs prescribed in 2023
Xolair30$100,770$3,359
Dupixent25$93,180$3,727
Nucala19$73,014$3,843
Trelegy Ellipta97$70,656$728
Breztri Aerosphere34$23,117$680
Symbicort42$16,977$404
Flovent Hfa14$4,262$304
Ventolin Hfa16$959$60
Albuterol Sulfate Hfa19$458$24
Azelastine13$255$20
Prednisone40$217$5
Montelukast22$184$8
Azithromycin11$60$5

2022: 15 drugs

Part D drugs prescribed in 2022
Trelegy Ellipta102$77,353$758
Dupixent16$54,495$3,406
Nucala15$52,244$3,483
Dupixent12$44,001$3,667
Breztri Aerosphere31$20,010$645
Symbicort34$13,126$386
Breo Ellipta21$9,010$429
Anoro Ellipta17$7,996$470
Flovent Hfa25$6,657$266
Budesonide-Formoterol11$4,439$404
Wixela Inhub11$2,112$192
Albuterol Sulfate Hfa36$1,857$52
Fluticasone Propionate17$313$18
Prednisone27$140$5
Montelukast14$119$9

2021: 9 drugs

Part D drugs prescribed in 2021
Nucala12$41,150$3,429
Trelegy Ellipta30$18,633$621
Symbicort33$15,190$460
Anoro Ellipta25$11,336$453
Flovent Hfa19$5,006$263
Albuterol Sulfate Hfa13$673$52
Prednisone27$162$6
Montelukast14$113$8
Pantoprazole11$105$10

2016: 18 drugs

Part D drugs prescribed in 2016
Ventolin Hfa15$756$50
Oxybutynin Chloride Er11$443$40
Polyethylene Glycol 335015$433$29
Valsartan14$395$28
Atorvastatin37$377$10
Metoprolol14$258$18
Hydralazine17$234$14
Finasteride14$153$11
Gabapentin12$136$11
Fluticasone Propionate21$135$6
Simvastatin21$108$5
Amlodipine Besylate28$82$3
Lisinopril22$81$4
Losartan24$81$3
Metformin14$75$5
Metoprolol19$58$3
Hydrochlorothiazide22$37$2
Furosemide20$32$2

Money from drug and device companies

$33,951 in 2025

Industry payments by year
2025839$31,315$33,951
2024519$14,099$15,880
202326$6,020$6,180
202212None$76
202111None$17
201911None$100

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GlaxoSmithKlineNucala$23,749
15 payments
  • Paid to speak or teach · 2025-12-04 · $2,600
  • Paid to speak or teach · 2025-11-25 · $1,300
  • Meals · 2025-11-19 · $125
  • Paid to speak or teach for Nucala · 2025-10-23 · $650
  • Paid to speak or teach · 2025-10-17 · $975
  • Consulting for Nucala · 2025-09-18 · $1,950
  • Consulting for Nucala · 2025-09-15 · $1,950
  • Consulting · 2025-06-25 · $13,000
  • Meals · 2025-05-17 · $12
  • Meals · 2025-05-17 · $62
  • Meals · 2025-05-17 · $108
  • Meals · 2025-05-17 · $104
  • Meals · 2025-05-17 · $120
  • Travel · 2025-05-16 · $610
  • Travel · 2025-05-16 · $182
Genentech USAXolair$5,631
8 payments
  • Travel · 2025-06-07 · $76
  • Travel · 2025-06-07 · $272
  • Meals · 2025-06-07 · $106
  • Meals · 2025-06-07 · $63
  • Meals · 2025-06-07 · $79
  • Meals · 2025-06-07 · $93
  • Consulting · 2025-06-07 · $4,888
  • Meals for Xolair · 2025-05-20 · $54
Regeneron Healthcare SolutionsDupixent$2,393
8 payments
  • Meals for Dupixent · 2025-09-10 · $135
  • Meals for Dupixent · 2025-05-21 · $90
  • Consulting for Dupixent · 2025-03-07 · $612
  • Consulting for Dupixent · 2025-03-07 · $612
  • Consulting for Dupixent · 2025-03-07 · $306
  • Consulting for Dupixent · 2025-03-07 · $306
  • Consulting for Dupixent · 2025-03-07 · $306
  • Meals for Dupixent · 2025-03-06 · $27
AstraZeneca Pharmaceuticals LPFasenra$2,025
4 payments
  • Consulting for Fasenra · 2025-06-02 · $1,860
  • Meals · 2025-05-20 · $39
  • Meals · 2025-05-18 · $15
  • Meals for Fasenra · 2025-05-18 · $110
Merck Sharp & DohmeWinrevair$75
1 payment
  • Meals for Winrevair · 2025-03-20 · $75
AmgenNone$34
1 payment
  • Education · 2025-08-15 · $34
See all 39 published payments
Every published payment
GlaxoSmithKlinePaid to speak or teach · 2025-12-04None$2,600
GlaxoSmithKlinePaid to speak or teach · 2025-11-25None$1,300
GlaxoSmithKlineMeals · 2025-11-19None$125
GlaxoSmithKlinePaid to speak or teach · 2025-10-23Nucala$650
GlaxoSmithKlinePaid to speak or teach · 2025-10-17None$975
GlaxoSmithKlineConsulting · 2025-09-18Nucala$1,950
GlaxoSmithKlineConsulting · 2025-09-15Nucala$1,950
Regeneron Healthcare SolutionsMeals · 2025-09-10Dupixent$135
InsmedEducation · 2025-09-09Brinsupri$17
AmgenEducation · 2025-08-15None$34
GlaxoSmithKlineConsulting · 2025-06-25None$13,000
Genentech USATravel · 2025-06-07None$76
Genentech USATravel · 2025-06-07None$272
Genentech USAMeals · 2025-06-07None$106
Genentech USAMeals · 2025-06-07None$63
Genentech USAMeals · 2025-06-07None$79
Genentech USAMeals · 2025-06-07None$93
Genentech USAConsulting · 2025-06-07None$4,888
AstraZeneca Pharmaceuticals LPConsulting · 2025-06-02Fasenra$1,860
Regeneron Healthcare SolutionsMeals · 2025-05-21Dupixent$90
AstraZeneca Pharmaceuticals LPMeals · 2025-05-20None$39
Genentech USAMeals · 2025-05-20Xolair$54
AstraZeneca Pharmaceuticals LPMeals · 2025-05-18None$15
AstraZeneca Pharmaceuticals LPMeals · 2025-05-18Fasenra$110
GlaxoSmithKlineMeals · 2025-05-17None$12
GlaxoSmithKlineMeals · 2025-05-17None$62
GlaxoSmithKlineMeals · 2025-05-17None$108
GlaxoSmithKlineMeals · 2025-05-17None$104
GlaxoSmithKlineMeals · 2025-05-17None$120
GlaxoSmithKlineTravel · 2025-05-16None$610
GlaxoSmithKlineTravel · 2025-05-16None$182
Merck Sharp & DohmeMeals · 2025-03-20Winrevair$75
Regeneron Healthcare SolutionsConsulting · 2025-03-07Dupixent$612
Regeneron Healthcare SolutionsConsulting · 2025-03-07Dupixent$612
Regeneron Healthcare SolutionsConsulting · 2025-03-07Dupixent$306
Regeneron Healthcare SolutionsConsulting · 2025-03-07Dupixent$306
Regeneron Healthcare SolutionsConsulting · 2025-03-07Dupixent$306
Regeneron Healthcare SolutionsMeals · 2025-03-06Dupixent$27
GenzymeMeals · 2025-02-06Wayrilz$27
See earlier years (2024, 2023, 2022, 2021, 2019)

2024: $15,880

Payments by company in 2024
GenzymeDupixent$11,378
8 payments
  • Meals for Dupixent · 2024-08-19 · $122
  • Paid to speak or teach for Dupixent · 2024-08-19 · $2,852
  • Travel · 2024-04-27 · $539
  • Travel · 2024-04-27 · $281
  • Meals · 2024-04-27 · $146
  • Meals · 2024-04-27 · $53
  • Meals · 2024-04-27 · $41
  • Consulting · 2024-04-27 · $7,344
GlaxoSmithKlineNucala$2,318
2 payments
  • Consulting for Nucala · 2024-09-27 · $2,275
  • Meals for Nucala · 2024-05-18 · $43
AstraZeneca Pharmaceuticals LPTezspire$1,763
2 payments
  • Consulting · 2024-05-23 · $1,628
  • Meals for Tezspire · 2024-05-17 · $135
Regeneron Healthcare SolutionsDupixent$391
6 payments
  • Meals for Dupixent · 2024-11-19 · $76
  • Meals for Dupixent · 2024-05-20 · $87
  • Meals for Dupixent · 2024-05-20 · $43
  • Meals for Dupixent · 2024-05-08 · $26
  • Meals · 2024-05-08 · $122
  • Meals for Dupixent · 2024-03-09 · $37
AmgenTezspire$30
1 payment
  • Meals for Tezspire · 2024-07-25 · $30

2023: $6,180

Payments by company in 2023
AstraZeneca Pharmaceuticals LPNone$4,418
1 payment
  • Consulting · 2023-10-24 · $4,418
Regeneron Healthcare SolutionsDupixent$1,762
5 payments
  • Meals for Dupixent · 2023-08-31 · $60
  • Meals for Dupixent · 2023-05-23 · $43
  • Meals for Dupixent · 2023-03-18 · $57
  • Consulting for Dupixent · 2023-02-06 · $534
  • Consulting for Dupixent · 2023-02-06 · $1,068

2022: $76

Payments by company in 2022
Regeneron Healthcare SolutionsDupixent$76
2 payments
  • Meals for Dupixent · 2022-11-07 · $64
  • Meals for Dupixent · 2022-08-25 · $13

2021: $17

Payments by company in 2021
Octapharma USACutaquig$17
1 payment
  • Meals for Cutaquig · 2021-04-21 · $17

2019: $100

Payments by company in 2019
Genentech USAEsbriet$100
1 payment
  • Education for Esbriet · 2019-05-19 · $100

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Regeneron Pharmaceuticals, Inc. · A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis · 2022Their institution$19,804
Regeneron Pharmaceuticals, Inc. · A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis · 2023Their institution$6,144

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1366784274
Licence
CA A148609, NY 278223California A148609: Current · expires 2026-12-31
Trained
Albert Einstein College of Medicine of Yeshiva University, 2013
Group
UCSF Medical Group Business Services · Regents of the University of California
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X)
Mailing address
400 Parnassus Ave, San Francisco, CA, 94143
NPI first listed
2013-03-19
NPI last updated
2025-07-09
NPI record certified
2025-07-09

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Community Dr, Manhasset, NY, 11030